Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $6.1000 (-8.55%) ($6.0000 - $6.4800) on Thu. Aug. 20, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.22% (three month average) | RSI | 57 | Latest Price | $6.1000(-8.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -1.7% a day on average for past five trading days. | Weekly Trend | ANPC advances 5.8% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) IGOV(10%) IPO(10%) XLB(10%) LIT(9%) TLT(8%) | Factors Impacting ANPC price | ANPC will decline at least -4.11% in a week (0% probabilities). SHY(-26%) XLU(-11%) IBB(-9%) TBT(-8%) XLRE(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.11% (StdDev 8.22%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.4 | 5 Day Moving Average | $6.8(-10.29%) | 10 Day Moving Average | $6.89(-11.47%) | 20 Day Moving Average | $6.4(-4.69%) | To recent high | -22.8% | To recent low | 19.8% | Market Cap | $52m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |